Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
CytomX Therapeutics
CTMX
$760M
| $5.01M | ﹤0.01% |
1,569,298
-175,878
| -10% | -$396K |
|
2777
SES AI
SES
$227M
| $5M | ﹤0.01% |
2,992,701
+1,237,105
| +70% | +$1.48M |
|
2778
ODDITY Tech
ODD
$595M
| $4.99M | ﹤0.01% |
80,120
+5,057
| +7% | +$328K |
|
2779
Fidelity D&D Bancorp
FDBC
$322M
| $4.99M | ﹤0.01% |
113,754
-411
| -0.4% | -$18K |
|
2780
Tredegar Corp
TG
$281M
| $4.99M | ﹤0.01% |
620,795
+31,520
| +5% | +$260K |
|
2781
Douglas Elliman
DOUG
$184M
| $4.98M | ﹤0.01% |
1,742,357
+34,534
| +2% | +$90.6K |
|
2782
Inogen
INGN
$154M
| $4.98M | ﹤0.01% |
609,289
-5,990
| -1% | -$44.8K |
|
2783
Health Catalyst
HCAT
$135M
| $4.96M | ﹤0.01% |
1,738,904
+76,449
| +5% | +$262K |
|
2784
Xponential Fitness
XPOF
$208M
| $4.95M | ﹤0.01% |
635,453
+25,268
| +4% | +$230K |
|
2785
OneWater Marine
ONEW
$204M
| $4.94M | ﹤0.01% |
312,047
+3,148
| +1% | +$49.8K |
|
|
OLPX
2786
DELISTED
Olaplex Holdings
OLPX
| $4.92M | ﹤0.01% |
3,758,986
+267,633
| +8% | +$384K |
|
2787
LCNB Corp
LCNB
$281M
| $4.92M | ﹤0.01% |
328,316
+1,807
| +0.6% | +$27.9K |
|
2788
Sky Harbour Group
SKYH
$396M
| $4.92M | ﹤0.01% |
498,312
+32,897
| +7% | +$336K |
|
2789
Perspective Therapeutics
CATX
$372M
| $4.91M | ﹤0.01% |
1,432,487
+49,673
| +4% | +$181K |
|
2790
First Community Corp
FCCO
$321M
| $4.91M | ﹤0.01% |
173,806
-926
| -0.5% | -$24.5K |
|
|
STLN
2791
Starling Oncology, Inc. Common Stock
STLN
$644M
| $4.89M | ﹤0.01% |
1,401,906
+122,463
| +10% | +$420K |
|
2792
DiaMedica Therapeutics
DMAC
$369M
| $4.89M | ﹤0.01% |
711,818
+81,670
| +13% | +$443K |
|
|
QMMM
2793
QMMM Holdings
QMMM
| $4.88M | ﹤0.01% |
+40,845
| New | +$1.04M |
|
|
ONTF
2794
DELISTED
ON24
ONTF
| $4.87M | ﹤0.01% |
852,134
-186
| -0% | -$1K |
|
2795
Chemung Financial Corp
CHMG
$401M
| $4.87M | ﹤0.01% |
92,732
-538
| -0.6% | -$28.1K |
|
2796
C&F Financial
CFFI
$288M
| $4.87M | ﹤0.01% |
72,413
-198
| -0.3% | -$13.4K |
|
2797
Codexis
CDXS
$175M
| $4.86M | ﹤0.01% |
1,992,404
+14,535
| +0.7% | +$39.6K |
|
2798
Asure Software
ASUR
$241M
| $4.86M | ﹤0.01% |
592,632
+6,126
| +1% | +$54.7K |
|
2799
Tonix Pharmaceuticals
TNXP
$214M
| $4.86M | ﹤0.01% |
200,934
+25,722
| +15% | +$955K |
|
2800
Hagerty
HGTY
$1.3B
| $4.84M | ﹤0.01% |
402,086
+147,452
| +58% | +$1.63M |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.